Celgene Corp.

Celgene Corp.

Celgene Corp.

Overview
Date Founded

1986

Headquarters

86 Morris Avenue, Summit, NJ, 07901, USA

Type of Company

Public

Employees (Worldwide)

10K - 1M

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Contact Data
Trying to get in touch with decision makers at Celgene Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Vice President, Chief Compliance Officer

President, Research & Early Development

President, Global Hematology & Oncology

Director & Vice President

Treasurer

Executive Vice President-Corporate Affairs & Strategic Market Access

Senior Vice President, Chief Information & Digital Officer

Senior Vice President, Global Regulatory Affairs

Secretary & Director

Board of Directors

Director & Vice President at Celgene Corp.

Vice President, Associate General Counsel & Corporate Secretary at Bristol-Myers Squibb Company

Paths to Celgene Corp.
Potential Connections via
Relationship Science
You
Celgene Corp.
Recent Transactions
Details Hidden

Amgen, Inc. purchases Celgene Corp. /OTEZLA Assets from Celgene Corp.

Details Hidden

Bristol-Myers Squibb Company purchases Celgene Corp.

Details Hidden

Celgene Corp. purchases Juno Therapeutics, Inc.

Transaction Advisors
Legal Advisor

Advised onCelgene Corp. purchases Juno Therapeutics, Inc.

Legal Advisor

Advised onBristol-Myers Squibb Company purchases Celgene Corp.

Investment Advisor

Advised onBristol-Myers Squibb Company purchases Celgene Corp.

Legal Advisor

Advised onCelgene Corp. purchases Juno Therapeutics, Inc.

Legal Advisor

Advised onCelgene Corp. purchases Juno Therapeutics, Inc.

Legal Advisor

Advised onCelgene Corp. purchases Abraxis BioScience, Inc.

Advisors & Consultants
Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Key Stats and Financials As of
Market Capitalization
$76.9B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
$100K - $250K
2020
$500 +
2019
Political Donations
$1,000
2014
$1,500
2014
$2,500
2014
Investments
Details Hidden

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Details Hidden

VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.

Details Hidden

OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD.

Investors
Details Hidden

Founder at The Cross Trust

Details Hidden

Senior Director, Global Regulatory Affairs at Celgene Corp.

Suppliers
Certara, Inc. Computer Software | Princeton, NJ

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Awards & Honors
Rank #305
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #305
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
Rank #12
2011
Forbes Magazine - The Nifty 50
Sponsored by
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Celgene Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Celgene Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Celgene Corp..